Erste Asset Management’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-21,600
| Closed | -$3.79M | – | 914 |
|
|
2021
Q3 | $3.79M | Hold |
21,600
| – | – | 0.08% | 229 |
|
|
2021
Q2 | $2.69M | Hold |
21,600
| – | – | 0.05% | 261 |
|
|
2021
Q1 | $2.87M | Buy |
21,600
+5,500
| +34% | +$732K | 0.07% | 231 |
|
|
2020
Q4 | $2.02M | Buy |
16,100
+200
| +1% | +$25.1K | 0.06% | 263 |
|
|
2020
Q3 | $1.8M | Hold |
15,900
| – | – | 0.06% | 261 |
|
|
2020
Q2 | $1.53M | Hold |
15,900
| – | – | 0.06% | 259 |
|
|
2020
Q1 | $1.36M | Sell |
15,900
-11,000
| -41% | -$941K | 0.08% | 223 |
|
|
2019
Q4 | $1.38M | Hold |
26,900
| – | – | 0.06% | 248 |
|
|
2019
Q3 | $1.09M | Hold |
26,900
| – | – | 0.06% | 254 |
|
|
2019
Q2 | $1.1M | Hold |
26,900
| – | – | 0.06% | 245 |
|
|
2019
Q1 | $1.21M | Sell |
26,900
-3,000
| -10% | -$135K | 0.07% | 229 |
|
|
2018
Q4 | $1.27M | Buy |
+29,900
| New | +$1.27M | 0.09% | 213 |
|